Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 26 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2020Genome-wide gene-environment analyses of major depressive disorder and reported lifetime traumatic experiences in UK BiobankColeman, J.R.I.; Peyrot, W.J.; Purves, K.L.; Davis, K.A.S.; Rayner, C.; Choi, S.W.; Hübel, C.; Gaspar, H.A.; Kan, C.; Van der Auwera, S.; Adams, M.J.; Lyall, D.M.; Choi, K.W.; Wray, N.R.; Ripke, S.; Mattheisen, M.; Trzaskowski, M.; Byrne, E.M.; Abdellaoui, A.; Adams, M.J.; et al.
2020Effect of intravenous tenecteplase dose on cerebral reperfusion before thrombectomy in patients with large vessel occlusion ischemic stroke: the EXTEND-IA TNK part 2 randomized clinical trialCampbell, B.C.V.; Mitchell, P.J.; Churilov, L.; Yassi, N.; Kleinig, T.J.; Dowling, R.J.; Yan, B.; Bush, S.J.; Thijs, V.; Scroop, R.; Simpson, M.; Brooks, M.; Asadi, H.; Wu, T.Y.; Shah, D.G.; Wijeratne, T.; Zhao, H.; Alemseged, F.; Ng, F.; Bailey, P.; et al.
2020A phenome-wide association and Mendelian Randomisation study of polygenic risk for depression in UK BiobankShen, X.; Howard, D.M.; Adams, M.J.; Hill, W.D.; Clarke, T.K.; Adams, M.J.; Clarke, T.K.; McIntosh, A.M.; Deary, I.J.; Wray, N.R.; Ripke, S.; Mattheisen, M.; Trzaskowski, M.; Byrne, E.M.; Abdellaoui, A.; Agerbo, E.; Air, T.M.; Andlauer, T.F.M.; Bacanu, S.A.; Bækvad-Hansen, M.; et al.
2020Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019Wang, H.; Abbas, K.M.; Abbasifard, M.; Abbasi-Kangevari, M.; Abbastabar, H.; Abd-Allah, F.; Abdelalim, A.; Abolhassani, H.; Abreu, L.G.; Abrigo, M.R.M.; Abushouk, A.I.; Adabi, M.; Adair, T.; Adebayo, O.M.; Adedeji, I.A.; Adekanmbi, V.; Adeoye, A.M.; Adetokunboh, O.O.; Advani, S.M.; Afshin, A.; et al.
2020Common genetic variation indicates separate causes for periventricular and deep white matter hyperintensitiesArmstrong, N.J.; Mather, K.A.; Sargurupremraj, M.; Knol, M.J.; Malik, R.; Satizabal, C.L.; Yanek, L.R.; Wen, W.; Gudnason, V.G.; Dueker, N.D.; Elliott, L.T.; Hofer, E.; Hofer, E.; Bis, J.; Jahanshad, N.; Li, S.; Logue, M.A.; Logue, M.A.; Luciano, M.; Scholz, M.; et al.
2021Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemiaOchi, Y.; Yoshida, K.; Huang, Y.-J.; Kuo, M.-C.; Nannya, Y.; Sasaki, K.; Mitani, K.; Hosoya, N.; Hiramoto, N.; Ishikawa, T.; Branford, S.; Shanmuganathan, N.; Ohyashiki, K.; Takahashi, N.; Takaku, T.; Tsuchiya, S.; Kanemura, N.; Nakamura, N.; Ueda, Y.; Yoshihara, S.; et al.
2020Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease StudyBourne, R.R.A.; Briant, P.S.; Flaxman, S.R.; Taylor, H.R.B.; Jonas, J.B.; Abdoli, A.A.; Abrha, W.A.; Abualhasan, A.; Abu-Gharbieh, E.G.; Adal, T.G.; Afshin, A.; Ahmadieh, H.; Alemayehu, W.; Alemzadeh, S.A.S.; Alfaar, A.S.; Alipour, V.; Androudi, S.; Arabloo, J.; Arditi, A.B.; Aregawi, B.B.; et al.
2023TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasmsShah, M.V.; Tran, E.N.H.; Shah, S.; Chhetri, R.; Baranwal, A.; Ladon, D.; Shultz, C.; Al-Kali, A.; Brown, A.L.; Chen, D.; Scott, H.S.; Greipp, P.; Thomas, D.; Alkhateeb, H.B.; Singhal, D.; Gangat, N.; Kumar, S.; Patnaik, M.M.; Hahn, C.N.; Kok, C.H.; et al.
2021Mesenteric lymphatic dysfunction promotes insulin resistance and represents a potential treatment target in obesityCao, E.; Watt, M.J.; Nowell, C.J.; Quach, T.; Simpson, J.S.; De Melo Ferreira, V.; Agarwal, S.; Chu, H.; Srivastava, A.; Anderson, D.; Gracia, G.; Lam, A.; Segal, G.; Hong, J.; Hu, L.; Phang, K.L.; Escott, A.B.J.; Windsor, J.A.; Phillips, A.R.J.; Creek, D.J.; et al.
2022Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemiaKimura, S.; Montefiori, L.; Iacobucci, I.; Zhao, Y.; Gao, Q.; Paietta, E.M.; Haferlach, C.; Laird, A.D.; Mead, P.E.; Gu, Z.; Stock, W.; Litzow, M.R.; Rowe, J.M.; Luger, S.M.; Hunger, S.P.; Ryland, G.; Schmidt, B.M.; Ekert, P.G.; Oshlack, A.; Grimmond, S.; et al.